Correspondence

Circular 004/2022: Gamma-Butyrolactone (GBL) and 1,4-Butanediol (1,4-BD): revocation of rescheduling

The Misuse of Drugs (Amendment) (Revocation) (England, Wales and Scotland) Regulations 2022 (SI 2022 No. 559) (“the 2022 Regulations”).

Documents

Details

This circular draws attention to the contents of the below Statutory Instrument, which will come into force on 14 June 2022:

  • The Misuse of Drugs (Amendment) (Revocation) (England, Wales and Scotland) Regulations 2022 (SI 2022 No. 559) (“the 2022 Regulations”)
Published 14 June 2022